谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Belzutifan Plus Cabozantinib As First-Line Treatment for Patients with Advanced Clear-Cell Renal Cell Carcinoma (LITESPARK-003): an Open-Label, Single-Arm, Phase 2 Study

Toni K. Choueiri,Jaime R. Merchan,Robert Figlin,David F. Mcdermott,Edward Arrowsmith,M. Dror Michaelson,Scott S. Tykodi,Elisabeth Heath,David R. Spigel,Anishka D'Souza, Laurent Kassalow,Rodolfo F. Perini,Donna Vickery,Todd M. Bauer

LANCET ONCOLOGY（2025）

引用 0|浏览2
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要